Abstract:Neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, and others, are characterized by progressive loss of neuronal cells, which causes memory impairment and cognitive decline. Mounting evidence demonstrated the possible implications of diverse biological processes, namely oxidative stress, mitochondrial dysfunction, aberrant cell cycle re-entry, post-translational modifications, protein aggregation, impaired proteasome dysfunction, autophagy, and many others that cause neuronal cell death. The condition worsens as there is no effective treatment for such diseases due to their complex pathogenesis and mechanism. Mounting evidence demonstrated the role of regulatory transcription factors, such as NFκβ, FoxO, Myc, CREB, and others that regulate the biological processes and diminish the disease progression and pathogenesis. Studies demonstrated that forkhead box O (FoxO) transcription factors had been implicated in the regulation of aging and longevity. Further, the functions of FoxO proteins are regulated by different post-translational modifications (PTMs), namely acetylation, and ubiquitination. Various studies concluded that FoxO proteins exert both neuroprotective and neurotoxic properties depending on their regulation mechanism and activity in the brain. Thus, understanding the nature of FoxO expression and activity in the brain will help develop effective therapeutic strategies. Herein, firstly, we discuss the role of FoxO protein in cell cycle regulation and cell proliferation, followed by the regulation of FoxO proteins through acetylation and ubiquitination. We also briefly explain the activity and expression pattern of FoxO proteins in the neuronal cells and explain the mechanism through which FoxO proteins are rescued from oxidative stress-induced neurotoxicity. Later on, we present a detailed view of the implication of FoxO proteins in neurodegenerative disease and FoxO proteins as an effective therapeutic target.

Lysine methylation of FOXO3 regulates oxidative stress-induced neuronal cell death.

Hdac2 Selectively Regulates Foxo3a-Mediated Gene Transcription During Oxidative Stress-Induced Neuronal Cell Death

Prolyl Hydroxylation by EglN2 Destabilizes FOXO3a by Blocking Its Interaction with the USP9x Deubiquitinase

SIRT1 Downregulation Mediated Manganese-induced Neuronal Apoptosis Through Activation of FOXO3a-Bim/PUMA Axis.

Mitochondria and Forkhead Box Protein O 3A

The rules and regulatory mechanisms of FOXO3 on inflammation, metabolism, cell death and aging in hosts

Tet1-mediated DNA Demethylation Regulates Neuronal Cell Death Induced by Oxidative Stress

FOXD3, Frequently Methylated in Colorectal Cancer, Acts As a Tumor Suppressor and Induces Tumor Cell Apoptosis under ER Stress Via P53.

Lysyl Oxidase 3 is a Dual-Specificity Enzyme Involved in STAT3 Deacetylation and Deacetylimination Modulation.

Anti-Neoplastic Activity of the Cytosolic Foxo1 Results from Autophagic Cell Death

Regulation of FOXOs and p53 by SIRT1 Modulators under Oxidative Stress

Demethylase FTO-Mediated m6A Modification of lncRNA MEG3 Activates Neuronal Pyroptosis via NLRP3 Signaling in Cerebral Ischemic Stroke

Synaptic NMDAR activity suppresses FOXO1 expression via a cis-acting FOXO binding site: FOXO1 is a FOXO target gene

The role of Foxo3a in neuron-mediated cognitive impairment

Cellular stress signaling activates type-I IFN response through FOXO3-regulated lamin posttranslational modification

FOXO3 Induces FOXO1-dependent Autophagy by Activating the AKT1 Signaling Pathway.

Arginine methylation of SKN-1 promotes oxidative stress resistance in Caenorhabditis elegans

The C-Abl-Mst1 Signaling Pathway Mediates Oxidative Stress-Induced Neuronal Cell Death

Energy Stress Modulation of AMPK/FoxO3 Signaling Inhibits Mitochondria-Associated Ferroptosis

FOXO and related transcription factors binding elements in the regulation of neurodegenerative disorders

Silencing of Circfoxo3 Protects HT22 Cells from Glutamate-Induced Oxidative Injury Via Regulating the Mitochondrial Apoptosis Pathway